LifeMD, Inc. (LFMDP)
USD 22.12
(1.28%)
USD 22.12
(1.28%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -20.59 Million USD | 54.25% |
| 2022 | -45.02 Million USD | 26.59% |
| 2021 | -61.32 Million USD | -1.32% |
| 2020 | -60.52 Million USD | -1615.42% |
| 2019 | -3.52 Million USD | -184.35% |
| 2018 | -1.24 Million USD | -2.89% |
| 2017 | -1.2 Million USD | -8.89% |
| 2016 | -1.1 Million USD | -1686.59% |
| 2015 | -61.99 Thousand USD | 86.54% |
| 2014 | -460.48 Thousand USD | -71.65% |
| 2013 | -268.26 Thousand USD | 39.8% |
| 2012 | -445.64 Thousand USD | 11.39% |
| 2011 | -502.92 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -6.76 Million USD | -81.36% |
| 2024 Q2 | -6.87 Million USD | -1.59% |
| 2023 Q1 | -10.08 Million USD | 12.89% |
| 2023 Q3 | -6.12 Million USD | 9.07% |
| 2023 Q4 | -3.73 Million USD | 39.04% |
| 2023 FY | -20.59 Million USD | 54.25% |
| 2023 Q2 | -6.73 Million USD | 33.22% |
| 2022 FY | -45.02 Million USD | 26.59% |
| 2022 Q1 | -13.46 Million USD | 25.64% |
| 2022 Q2 | -13.08 Million USD | 2.82% |
| 2022 Q3 | -8.43 Million USD | 35.52% |
| 2022 Q4 | -11.57 Million USD | -37.17% |
| 2021 Q4 | -18.11 Million USD | -26.18% |
| 2021 Q1 | -11.6 Million USD | 64.02% |
| 2021 Q2 | -16.83 Million USD | -45.06% |
| 2021 Q3 | -14.35 Million USD | 14.72% |
| 2021 FY | -61.32 Million USD | -1.32% |
| 2020 Q4 | -32.25 Million USD | -56.39% |
| 2020 Q1 | -2.39 Million USD | -236.55% |
| 2020 Q2 | -3.37 Million USD | -41.11% |
| 2020 Q3 | -20.62 Million USD | -510.29% |
| 2020 FY | -60.52 Million USD | -1615.42% |
| 2019 Q3 | -943.8 Thousand USD | -15.36% |
| 2019 Q4 | -711.54 Thousand USD | 24.61% |
| 2019 FY | -3.52 Million USD | -184.35% |
| 2019 Q2 | -818.1 Thousand USD | -23.26% |
| 2019 Q1 | -663.74 Thousand USD | 6.79% |
| 2018 Q1 | 627.27 Thousand USD | 385.67% |
| 2018 FY | -1.24 Million USD | -2.89% |
| 2018 Q4 | -712.09 Thousand USD | -29.71% |
| 2018 Q3 | -548.97 Thousand USD | 9.56% |
| 2018 Q2 | -607.03 Thousand USD | -196.77% |
| 2017 Q1 | -1.04 Million USD | -68.83% |
| 2017 Q2 | 737.48 Thousand USD | 170.59% |
| 2017 Q4 | -219.58 Thousand USD | 67.66% |
| 2017 FY | -1.2 Million USD | -8.89% |
| 2017 Q3 | -679.06 Thousand USD | -192.08% |
| 2016 Q1 | -62.04 Thousand USD | -22.27% |
| 2016 FY | -1.1 Million USD | -1686.59% |
| 2016 Q3 | -226.65 Thousand USD | -13.34% |
| 2016 Q2 | -199.97 Thousand USD | -222.29% |
| 2016 Q4 | -618.86 Thousand USD | -173.05% |
| 2015 FY | -61.99 Thousand USD | 86.54% |
| 2015 Q4 | -50.74 Thousand USD | -725.06% |
| 2015 Q3 | 8119.00 USD | 138.61% |
| 2015 Q2 | -21.02 Thousand USD | -1362.18% |
| 2015 Q1 | 1666.00 USD | 101.16% |
| 2014 Q1 | -140.93 Thousand USD | -96.97% |
| 2014 Q4 | -144.13 Thousand USD | -38.72% |
| 2014 Q3 | -103.9 Thousand USD | -45.31% |
| 2014 Q2 | -71.5 Thousand USD | 49.27% |
| 2014 FY | -460.48 Thousand USD | -71.65% |
| 2013 Q3 | -139.36 Thousand USD | -779.06% |
| 2013 Q2 | -15.85 Thousand USD | 61.79% |
| 2013 Q1 | -41.48 Thousand USD | 41.7% |
| 2013 Q4 | -71.55 Thousand USD | 48.66% |
| 2013 FY | -268.26 Thousand USD | 39.8% |
| 2012 FY | -445.64 Thousand USD | 11.39% |
| 2012 Q1 | -28.29 Thousand USD | 0.0% |
| 2012 Q2 | -186.84 Thousand USD | -560.38% |
| 2012 Q3 | -159.34 Thousand USD | 14.72% |
| 2012 Q4 | -71.16 Thousand USD | 55.34% |
| 2011 FY | -502.92 Thousand USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| CannBioRx Life Sciences Corp. | -19.93 Million USD | -3.315% |
| BIMI International Medical Inc. | -22.35 Million USD | 7.859% |
| China Jo-Jo Drugstores, Inc. | -4.23 Million USD | -386.417% |
| Harrow Health, Inc. 8.625% Senior Notes due 2026 | -24.41 Million USD | 15.628% |
| Harrow Health, Inc. 11.875% Senior Notes due 2027 | -24.41 Million USD | 15.628% |
| Leafly Holdings, Inc. | -9.49 Million USD | -116.846% |
| Leafly Holdings, Inc. | -9.49 Million USD | -116.846% |
| LifeMD, Inc. | -20.59 Million USD | -0.0% |
| TRxADE HEALTH, Inc. | -17.84 Million USD | -15.425% |
| PetMed Express, Inc. | -7.46 Million USD | -175.938% |
| Walgreens Boots Alliance, Inc. | -8.63 Billion USD | 99.762% |